These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 1909584)
1. Efficacy of misoprostol and ranitidine in the prevention of duodenal ulcer relapse and its correlation with endogenous gastric prostanoid synthesis. Goldin E; Karmeli F; Rachmilewitz D Aliment Pharmacol Ther; 1991 Apr; 5(2):173-80. PubMed ID: 1909584 [TBL] [Abstract][Full Text] [Related]
2. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. Rachmilewitz D; Ligumsky M; Fich A; Goldin E; Eliakim A; Karmeli F Gastroenterology; 1986 Apr; 90(4):963-9. PubMed ID: 3081399 [TBL] [Abstract][Full Text] [Related]
3. A comparative study of misoprostol and ranitidine in the healing of duodenal ulcers. A double-blind controlled trial. Simjee AE; Spitaels JM; Pettengell KE; Manion GL S Afr Med J; 1987 Jul; 72(1):15-7. PubMed ID: 3110981 [TBL] [Abstract][Full Text] [Related]
4. Comparison of misoprostol and ranitidine in the treatment of duodenal ulcer. Goldin E; Fich A; Eliakim R; Zimmerman J; Ligumsky M; Rachmilewitz D Isr J Med Sci; 1988 Jun; 24(6):282-5. PubMed ID: 3136094 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
6. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and chronic active inflammation of the duodenum and stomach in duodenal ulcer patients treated with ranitidine, misoprostol, or an acid-neutralizing agent. Madsen JE; Vetvik K; AAse S Scand J Gastroenterol; 1991 May; 26(5):465-70. PubMed ID: 1908115 [TBL] [Abstract][Full Text] [Related]
9. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Agrawal NM; Saffouri B; Kruss DM; Callison DA; Dajani EZ Dig Dis Sci; 1985 Nov; 30(11 Suppl):164S-170S. PubMed ID: 3932050 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of prostanoids in the treatment of gastric ulcer. Rachmilewitz D Clin Invest Med; 1987 May; 10(3):238-42. PubMed ID: 3113800 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring. Savarino V; Scalabrini P; Mela GS; di Timoteo E; Percario G; Magnolia MR; Celle G Dig Dis Sci; 1988 Mar; 33(3):293-7. PubMed ID: 3125025 [TBL] [Abstract][Full Text] [Related]
13. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study. Brand DL; Roufail WM; Thomson AB; Tapper EJ Dig Dis Sci; 1985 Nov; 30(11 Suppl):147S-158S. PubMed ID: 3932048 [TBL] [Abstract][Full Text] [Related]
14. Ranitidine in the prevention of gastric and duodenal ulcer relapse. Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956 [TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drugs for cancer pain: comparison between misoprostol and ranitidine in prevention of upper gastrointestinal damage. Valentini M; Cannizzaro R; Poletti M; Bortolussi R; Fracasso A; Testa V; Sozzi M; Fornasarig M; Bortoluzzi F; Grazioli I J Clin Oncol; 1995 Oct; 13(10):2637-42. PubMed ID: 7595718 [TBL] [Abstract][Full Text] [Related]
16. [The use of misoprostol in prevention of gastric disease from nonsteroidal anti-inflammatory drugs in oral-maxillofacial surgery]. Bocca M; Giordano M; Del Pizzo M; Nelken A; Ghiggia M; Pomatto E Minerva Ortognatod; 1990; 8(2):139-41. PubMed ID: 2126183 [TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Lanza FL; Aspinall RL; Swabb EA; Davis RE; Rack MF; Rubin A Gastroenterology; 1988 Aug; 95(2):289-94. PubMed ID: 3134266 [TBL] [Abstract][Full Text] [Related]
18. Rioprostil and ranitidine in the prevention of duodenal ulcer relapse. Rampal P; Raillat A; Viteau JM; Slama JL; Lavignolle A; Bedenne L; Veyres B; Toulet J; Vray M; Prunieras F Scand J Gastroenterol Suppl; 1989; 164():146-50; discussion 150-1. PubMed ID: 2510259 [TBL] [Abstract][Full Text] [Related]
19. The therapeutic efficacy of misoprostol in peptic ulcer disease. Watkinson G; Hopkins A; Akbar FA Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682 [TBL] [Abstract][Full Text] [Related]
20. Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study. Jiranek GC; Kimmey MB; Saunders DR; Willson RA; Shanahan W; Silverstein FE Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):656-61. PubMed ID: 2491827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]